{"hands_on_practices": [{"introduction": "The International Health Regulations (IHR) are not just a theoretical document; they are a practical tool for global security. At the heart of the IHR is the Annex 2 decision instrument, which guides countries in determining whether a health event requires notification to the WHO. This exercise [@problem_id:4528872] places you in the role of a national public health official facing a mysterious outbreak, challenging you to apply the four key criteria to make the crucial, time-sensitive decision to notify.", "problem": "A tertiary-care hospital in Country Z located approximately $25~\\mathrm{km}$ from an international border detects a cluster of severe acute respiratory illness among patients and healthcare workers over $72$ hours. There are $11$ confirmed cases with $3$ fatalities, yielding a case fatality proportion of approximately $27\\%$. Routine diagnostic panels for common causes (including seasonal influenza and Severe Acute Respiratory Syndrome Coronavirus 2) are negative, and the clinical picture is not consistent with known locally circulating pathogens. Epidemiologic investigation identifies several cases with no community exposures but clear overlap on inpatient wards and shared procedures, strongly suggesting ongoing nosocomial transmission. Two affected healthcare workers commute daily from the neighboring country, and one became symptomatic while off duty at home. National media and several international outlets are reporting a “mystery hospital outbreak,” and local tour operators have issued advisories leading to cancellations from foreign clients.\n\nUnder the International Health Regulations (IHR, 2005), the Ministry of Health conducts an initial risk assessment. Based on fundamental obligations regarding notification and use of the decision instrument for events that may constitute a Public Health Emergency of International Concern (PHEIC), select the single best statement about whether immediate notification to the World Health Organization (WHO) is required.\n\nA. Immediate notification to the World Health Organization (WHO) is required because the event is unusual or unexpected, has a serious public health impact, and presents a significant risk of international concern, meeting the International Health Regulations (IHR, 2005) Annex 2 notification threshold.\n\nB. Notification should be delayed until laboratory confirmation of the specific etiology, because the International Health Regulations (IHR, 2005) require identification of the pathogen before reporting to the World Health Organization (WHO).\n\nC. Notification is not required because nosocomial transmission indicates containment to a single facility and therefore does not satisfy the International Health Regulations (IHR, 2005) criteria for international notification.\n\nD. Notification is optional; the country should wait to see if the World Health Organization (WHO) requests information in response to media coverage before deciding whether to notify.\n\nE. Notification is only required if the event matches one of the specifically listed always-notifiable diseases (for example, smallpox, poliomyelitis due to wild-type poliovirus, human influenza caused by a new subtype, Severe Acute Respiratory Syndrome), which this event does not; therefore no notification is currently required.", "solution": "The problem statement describes an epidemiological event and asks whether it requires immediate notification to the World Health Organization (WHO) under the International Health Regulations (IHR, 2005).\n\n**Problem Validation**\n\nFirst, a validation of the problem statement is necessary.\n\n**Step 1: Extract Givens**\n- **Event:** A cluster of severe acute respiratory illness.\n- **Location:** Tertiary-care hospital in Country Z, approximately $25$ $\\mathrm{km}$ from an international border.\n- **Timeline:** Developed over $72$ hours.\n- **Incidence and Mortality:** $11$ confirmed cases with $3$ fatalities.\n- **Case Fatality Proportion (CFP):** Approximately $27\\%$ ($3/11 \\approx 0.273$).\n- **Etiology:** Unknown. Routine diagnostic panels for common respiratory pathogens are negative. Clinical presentation is not consistent with known local pathogens.\n- **Transmission:** Evidence strongly suggests ongoing nosocomial (hospital-acquired) transmission.\n- **International Linkages:** Two affected healthcare workers are cross-border commuters from a neighboring country; one became symptomatic in the neighboring country.\n- **Socioeconomic Impact:** Media reports of a \"mystery hospital outbreak\" are circulating internationally, and local tour operators are experiencing cancellations from foreign clients.\n- **Framework for Assessment:** International Health Regulations (IHR, 2005), specifically the decision instrument for notification.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The scenario is scientifically and epidemiologically plausible. It presents a classic public health challenge: an outbreak of a disease of unknown etiology with high severity and potential for international spread. The concepts used (nosocomial transmission, CFP, IHR, PHEIC) are standard in epidemiology and global health.\n- **Well-Posedness:** The problem is well-posed. It provides sufficient, consistent information to apply the specified regulatory tool (the IHR (2005) Annex 2 decision instrument) to arrive at a definitive answer.\n- **Objectivity:** The problem statement is objective and fact-based, free of subjective language.\n\n**Verdict:** The problem is valid. It is a well-constructed scenario for applying the principles of global health governance.\n\n**Solution Derivation**\n\nThe core of this problem lies in the correct application of the International Health Regulations (IHR, 2005). The IHR mandates that State Parties notify the WHO of events that may constitute a Public Health Emergency of International Concern (PHEIC). Article $6$ of the IHR obliges states to use the decision instrument provided in Annex $2$ to assess events.\n\nThe Annex $2$ decision instrument poses four questions. An event requires notification to the WHO if the answer is \"yes\" to **at least two** of these four questions:\n1. Is the public health impact of the event serious?\n2. Is the event unusual or unexpected?\n3. Is there a significant risk of international spread?\n4. Is there a significant risk of international travel or trade restrictions?\n\nLet us apply these criteria to the given scenario:\n\n1.  **Is the public health impact of the event serious?**\n    **Yes.** The event involves severe acute respiratory illness. There are $3$ fatalities among $11$ cases, yielding a case fatality proportion (CFP) of $3/11 \\approx 27\\%$. A CFP of this magnitude is exceptionally high and clearly denotes a serious public health impact. Furthermore, the occurrence of nosocomial transmission, especially among healthcare workers, threatens the capacity of the healthcare system itself, amplifying the seriousness of the event.\n\n2.  **Is the event unusual or unexpected?**\n    **Yes.** The problem states that the illness is caused by an unknown agent. Diagnostic tests for common pathogens are negative, and the \"clinical picture is not consistent with known locally circulating pathogens.\" An outbreak of a novel or unidentified pathogen is, by definition, unusual and unexpected.\n\n3.  **Is there a significant risk of international spread?**\n    **Yes.** The hospital is located only $25$ $\\mathrm{km}$ from an international border. More critically, the problem states that two affected healthcare workers commute from a neighboring country, and one of them became symptomatic while in that other country. This is not merely a risk of spread; it is a confirmed instance of the potential infectious agent having already crossed an international border in an infected individual. This constitutes a very significant risk of international spread.\n\n4.  **Is there a significant risk of international travel or trade restrictions?**\n    **Yes.** The text explicitly mentions that \"local tour operators have issued advisories leading to cancellations from foreign clients.\" This is a direct impact on international travel to the region. It indicates that the event is already causing disruptions and that formal international travel or trade restrictions are a significant possibility.\n\n**Conclusion of Assessment:**\nThe event meets all four criteria of the Annex $2$ decision instrument. Since only two \"yes\" answers are required to trigger the notification obligation, notification to the WHO is mandatory. According to Article $6.1$ of the IHR (2005), this notification must be made within $24$ hours of the assessment. Therefore, immediate notification is required.\n\n**Evaluation of Options**\n\n**A. Immediate notification to the World Health Organization (WHO) is required because the event is unusual or unexpected, has a serious public health impact, and presents a significant risk of international concern, meeting the International Health Regulations (IHR, 2005) Annex $2$ notification threshold.**\nThis statement accurately reflects the analysis above. The event's serious impact (high CFP), unusual nature (unknown etiology), and risk of international spread and/or travel restrictions (cross-border commuters, tourism cancellations) satisfy the criteria of Annex $2$. Therefore, immediate notification is required.\n**Verdict: Correct.**\n\n**B. Notification should be delayed until laboratory confirmation of the specific etiology, because the International Health Regulations (IHR, 2005) require identification of the pathogen before reporting to the World Health Organization (WHO).**\nThis assertion is factually incorrect. A central innovation of the IHR (2005) was a shift from a disease-specific notification system to an \"all-hazards,\" event-based approach encapsulated by the Annex $2$ instrument. This instrument is designed to function precisely in situations where the etiology is unknown. Delaying notification until pathogen identification would undermine the IHR's core purpose of timely risk assessment and rapid international response.\n**Verdict: Incorrect.**\n\n**C. Notification is not required because nosocomial transmission indicates containment to a single facility and therefore does not satisfy the International Health Regulations (IHR, 2005) criteria for international notification.**\nThis reasoning is flawed on multiple levels. First, the premise of \"containment\" is explicitly contradicted by the given fact that infected healthcare workers commute across an international border. Second, even if the event were geographically contained, it would still require notification because it meets the \"serious public health impact\" and \"unusual or unexpected\" criteria, satisfying the \"two out of four\" rule.\n**Verdict: Incorrect.**\n\n**D. Notification is optional; the country should wait to see if the World Health Organization (WHO) requests information in response to media coverage before deciding whether to notify.**\nThis statement misrepresents the legal obligations under the IHR (2005). Article $6$ uses the binding term \"shall notify,\" indicating a mandatory, not optional, duty for the State Party. Awaiting a query from the WHO, which may indeed be triggered by media reports or other informal sources (per Article $9$), does not absolve the state of its primary and proactive notification requirement.\n**Verdict: Incorrect.**\n\n**E. Notification is only required if the event matches one of the specifically listed always-notifiable diseases (for example, smallpox, poliomyelitis due to wild-type poliovirus, human influenza caused by a new subtype, Severe Acute Respiratory Syndrome), which this event does not; therefore no notification is currently required.**\nThis reflects a critical misunderstanding of the IHR (2005) notification framework. The IHR employs a dual-track system. While it is true that four diseases are always notifiable, this is not the exclusive pathway for notification. The primary mechanism for all other events of potential international concern is the Annex $2$ decision instrument. This option completely ignores the existence and application of Annex $2$, which is the relevant tool for this scenario.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4528872"}, {"introduction": "Beyond notification, the IHR provides a framework for implementing public health measures to prevent the international spread of disease. However, any such measure, like traveler screening, must be based on scientific principles and risk assessment. This problem [@problem_id:4528901] takes you behind the policy debate, asking you to use fundamental concepts of probability and epidemiology to quantify the expected impact of a pre-departure testing program. By calculating the number of cases averted, you will see how mathematical modeling provides a vital evidence base for decision-making in global health.", "problem": "A State Party to the World Health Organization (WHO) International Health Regulations (IHR, 2005) considers implementing pre-departure testing to reduce the risk of importing an acute infectious disease. Each day, there are $n=1000$ travelers departing from the origin to the destination. The true point prevalence of active infection among would-be travelers at the origin is $p=0.01$. A pre-departure diagnostic test is used that has sensitivity $\\text{Se}=0.80$, defined as the conditional probability $P(\\text{test positive} \\mid \\text{infected})=\\text{Se}$. Assume, for the purpose of expectation, that infection statuses are independent across travelers and that test outcomes across different travelers are independent. Assume test specificity is $1$ so that uninfected travelers are not prevented from travel by false positives. All infected travelers who test positive are denied boarding and do not travel.\n\nUsing only the axioms of probability, the definition of prevalence $p$ as the individual probability of infection, the definition of test sensitivity $\\text{Se}$, and linearity of expectation, derive from first principles the expected number of infected travelers who would arrive at the destination per day without testing and with pre-departure testing. Then compute the expected reduction in imported infected travelers attributable to the testing intervention.\n\nExpress your final answer as a single number of cases prevented per day. No rounding is required. Use the unit “cases per day” in your interpretation, but do not include units in the final numeric answer.", "solution": "The problem is assessed to be valid as it is scientifically grounded in epidemiology and probability theory, self-contained, and objectively phrased. We proceed with a formal solution derived from first principles.\n\nLet $n$ be the total number of travelers departing each day, with $n=1000$. Let $p$ be the prevalence of the infection, given as $p=0.01$. The sensitivity of the diagnostic test is $\\text{Se}=0.80$. The specificity is $\\text{Sp}=1$.\n\nWe define an indicator random variable $I_k$ for each traveler $k \\in \\{1, 2, \\dots, n\\}$.\n$I_k = 1$ if traveler $k$ is infected.\n$I_k = 0$ if traveler $k$ is not infected.\n\nThe problem states that the prevalence $p$ is the individual probability of infection. Thus, for any traveler $k$:\n$$P(I_k = 1) = p$$\n$$P(I_k = 0) = 1 - p$$\nThe expected value of this Bernoulli random variable is $E[I_k] = 1 \\cdot P(I_k=1) + 0 \\cdot P(I_k=0) = p$.\n\nFirst, we calculate the expected number of infected travelers arriving at the destination per day in the absence of any testing intervention. Let this quantity be $E[X]$. In this scenario, all $n$ travelers board the flight. The total number of infected travelers arriving is $X = \\sum_{k=1}^{n} I_k$. Using the linearity of expectation, we have:\n$$E[X] = E\\left[\\sum_{k=1}^{n} I_k\\right] = \\sum_{k=1}^{n} E[I_k]$$\nSince $E[I_k] = p$ for all $k$,\n$$E[X] = \\sum_{k=1}^{n} p = np$$\nSubstituting the given values:\n$$E[X] = 1000 \\times 0.01 = 10$$\nSo, without testing, the expected number of infected arrivals per day is $10$.\n\nNext, we calculate the expected number of infected travelers arriving at the destination with the pre-departure testing intervention. Let this quantity be $E[Y]$. An infected traveler arrives if and only if two events occur jointly: the traveler is infected, AND they test negative. Uninfected travelers are irrelevant to this count.\n\nLet $A_k$ be an indicator random variable where $A_k=1$ if traveler $k$ is infected and arrives at the destination, and $A_k=0$ otherwise. For $A_k$ to be $1$, traveler $k$ must be infected ($I_k=1$) and must test negative. Let $T_k^-$ denote the event that traveler $k$ tests negative. We need to find the probability $P(A_k=1)$.\n$$P(A_k=1) = P(I_k=1 \\text{ and } T_k^-)$$\nUsing the definition of conditional probability, this can be written as:\n$$P(A_k=1) = P(T_k^- \\mid I_k=1) \\cdot P(I_k=1)$$\nWe are given $P(I_k=1) = p$. The probability $P(T_k^- \\mid I_k=1)$ is the false-negative rate of the test. The sensitivity, $\\text{Se}$, is defined as the conditional probability of a positive test given infection, $P(T_k^+ \\mid I_k=1) = \\text{Se}$. Since a test result is either positive or negative, we have:\n$$P(T_k^- \\mid I_k=1) = 1 - P(T_k^+ \\mid I_k=1) = 1 - \\text{Se}$$\nTherefore, the probability that any given traveler is infected and arrives at the destination is:\n$$P(A_k=1) = (1 - \\text{Se})p$$\nThe expected value of this indicator variable is $E[A_k] = P(A_k=1) = (1 - \\text{Se})p$.\n\nThe total number of infected travelers arriving with the testing intervention is $Y = \\sum_{k=1}^{n} A_k$. Using the linearity of expectation:\n$$E[Y] = E\\left[\\sum_{k=1}^{n} A_k\\right] = \\sum_{k=1}^{n} E[A_k] = \\sum_{k=1}^{n} (1 - \\text{Se})p = n(1 - \\text{Se})p$$\nSubstituting the given values:\n$$E[Y] = 1000 \\times (1 - 0.80) \\times 0.01 = 1000 \\times 0.20 \\times 0.01 = 2$$\nWith pre-departure testing, the expected number of infected arrivals per day is $2$. The assumption of specificity $\\text{Sp}=1$ ensures that uninfected individuals test negative and travel, but this does not affect the count of infected arrivals.\n\nFinally, we compute the expected reduction in imported infected travelers, which is the difference between the expected number of infected arrivals without testing and with testing. Let this reduction be $R$.\n$$R = E[X] - E[Y]$$\n$$R = np - n(1 - \\text{Se})p$$\nFactoring out $np$, we get:\n$$R = np(1 - (1 - \\text{Se})) = np(1 - 1 + \\text{Se}) = np\\text{Se}$$\nThis result signifies that the expected number of cases prevented is the expected number of total infected travelers ($np$) multiplied by the probability that the test correctly identifies an infected person ($\\text{Se}$).\n\nSubstituting the numerical values:\n$$R = 1000 \\times 0.01 \\times 0.80 = 10 \\times 0.80 = 8$$\n\nThus, the expected reduction in imported infected travelers attributable to the testing intervention is $8$ cases per day.", "answer": "$$\\boxed{8}$$", "id": "4528901"}, {"introduction": "Effective global health governance relies on strong national systems, but building these core capacities requires strategic investment. Public health authorities constantly face the challenge of allocating limited funds to achieve the greatest possible impact. This exercise [@problem_id:4528882] introduces a powerful approach from health economics, challenging you to solve a constrained optimization problem. You will determine the most effective way to distribute a budget across different IHR capacities to maximize a country’s preparedness, demonstrating how quantitative analysis can guide high-level policy and resource allocation.", "problem": "A national public health authority seeks to allocate a fixed preparedness budget across three International Health Regulations (IHR) core capacities—surveillance, laboratory, and risk communication—to reduce the expected time-to-detection of public health events while improving compliance with World Health Organization (WHO) benchmarks. Assume that each capacity exhibits diminishing marginal returns consistent with concave utility, and that the authority aggregates benefits via a weighted sum where weights reflect the relative contribution of each capacity to both time-to-detection reduction and IHR compliance. Let the decision variables be $x_{s}$, $x_{\\ell}$, and $x_{r}$, representing the allocations (in million United States dollars (USD)) to surveillance, laboratory, and risk communication, respectively.\n\nThe objective function is\n$$\nJ(x_{s},x_{\\ell},x_{r}) \\;=\\; w_{s}\\,\\ln\\!\\big(1+\\beta_{s} x_{s}\\big)\\;+\\;w_{\\ell}\\,\\ln\\!\\big(1+\\beta_{\\ell} x_{\\ell}\\big)\\;+\\;w_{r}\\,\\ln\\!\\big(1+\\beta_{r} x_{r}\\big),\n$$\nwhere $w_{s}$, $w_{\\ell}$, and $w_{r}$ are positive weights, and $\\beta_{s}$, $\\beta_{\\ell}$, and $\\beta_{r}$ are positive responsiveness parameters (per million USD) capturing how quickly investments translate into detection-time reductions and IHR compliance improvements.\n\nThe authority’s total budget is $B=10$ million USD, with feasibility constraints $x_{s}\\ge 0$, $x_{\\ell}\\ge 0$, and $x_{r}\\ge 0$, and the resource constraint $x_{s}+x_{\\ell}+x_{r}=B$.\n\nUse the parameter values $w_{s}=0.5$, $w_{\\ell}=0.3$, $w_{r}=0.2$, $\\beta_{s}=0.25$, $\\beta_{\\ell}=0.20$, and $\\beta_{r}=0.50$ (all $\\beta$ in units of per million USD). Formulate and solve the constrained optimization problem to find the optimal allocation $\\big(x_{s}^{\\star},x_{\\ell}^{\\star},x_{r}^{\\star}\\big)$.\n\nExpress the final allocations in million USD and round each to four significant figures.", "solution": "### Step 1: Extract Givens\nThe problem provides the following information:\n- **Decision variables**: $x_{s}$, $x_{\\ell}$, $x_{r}$ representing financial allocations (in million USD) to surveillance, laboratory, and risk communication, respectively.\n- **Objective function to be maximized**:\n$$J(x_{s},x_{\\ell},x_{r}) = w_{s}\\,\\ln(1+\\beta_{s} x_{s}) + w_{\\ell}\\,\\ln(1+\\beta_{\\ell} x_{\\ell}) + w_{r}\\,\\ln(1+\\beta_{r} x_{r})$$\n- **Constraints**:\n  - Budget constraint: $x_{s}+x_{\\ell}+x_{r}=B$\n  - Non-negativity constraints: $x_{s}\\ge 0$, $x_{\\ell}\\ge 0$, $x_{r}\\ge 0$\n- **Parameter values**:\n  - Total budget: $B = 10$ (million USD)\n  - Weights: $w_{s}=0.5$, $w_{\\ell}=0.3$, $w_{r}=0.2$\n  - Responsiveness parameters: $\\beta_{s}=0.25$, $\\beta_{\\ell}=0.20$, $\\beta_{r}=0.50$ (per million USD)\n\n### Step 2: Validate Using Extracted Givens\nThe problem is a well-defined constrained optimization task.\n- **Scientifically Grounded:** The model uses a standard logarithmic utility function to represent diminishing marginal returns, a fundamental concept in economics and resource allocation. The application to public health preparedness is a valid use of operations research methodology. The problem is grounded in established mathematical and economic principles.\n- **Well-Posed:** The objective function $J$ is a sum of logarithmic functions, which are strictly concave. Thus, $J$ is strictly concave. The constraint set defined by $x_{s}+x_{\\ell}+x_{r}=B$ and $x_{i} \\ge 0$ for $i \\in \\{s, \\ell, r\\}$ is a compact and convex set (a simplex). The maximization of a strictly concave function over a non-empty, compact, convex set guarantees the existence of a unique solution.\n- **Objective:** The problem is stated using precise mathematical formalism and objective parameters. It is free of ambiguity or subjective claims.\n- **Completeness and Consistency:** All necessary parameters and constraints are provided. There are no contradictions in the setup.\n\n### Step 3: Verdict and Action\nThe problem is valid. The solution will proceed by formulating and solving the constrained optimization problem.\n\n### Solution Derivation\nThe problem is to maximize the objective function $J(x_{s},x_{\\ell},x_{r})$ subject to the equality constraint $x_{s}+x_{\\ell}+x_{r}=B$ and non-negativity constraints $x_{s}\\ge 0$, $x_{\\ell}\\ge 0$, and $x_{r}\\ge 0$. This can be solved using the method of Lagrange multipliers.\n\nFirst, we define the Lagrangian function $\\mathcal{L}(x_s, x_\\ell, x_r, \\lambda)$, incorporating the budget constraint. We will handle the non-negativity constraints later by checking the validity of the solution.\n$$ \\mathcal{L}(x_s, x_\\ell, x_r, \\lambda) = J(x_s, x_\\ell, x_r) - \\lambda(x_s + x_\\ell + x_r - B) $$\n$$ \\mathcal{L}(x_s, x_\\ell, x_r, \\lambda) = w_{s}\\,\\ln(1+\\beta_{s} x_{s}) + w_{\\ell}\\,\\ln(1+\\beta_{\\ell} x_{\\ell}) + w_{r}\\,\\ln(1+\\beta_{r} x_{r}) - \\lambda(x_s + x_\\ell + x_r - B) $$\nTo find the optimal allocation, we take the partial derivatives of $\\mathcal{L}$ with respect to each decision variable and the Lagrange multiplier $\\lambda$, and set them to zero. This gives the first-order necessary conditions for an extremum.\n\n$$ \\frac{\\partial \\mathcal{L}}{\\partial x_s} = \\frac{w_s \\beta_s}{1+\\beta_s x_s} - \\lambda = 0 $$\n$$ \\frac{\\partial \\mathcal{L}}{\\partial x_\\ell} = \\frac{w_\\ell \\beta_\\ell}{1+\\beta_\\ell x_\\ell} - \\lambda = 0 $$\n$$ \\frac{\\partial \\mathcal{L}}{\\partial x_r} = \\frac{w_r \\beta_r}{1+\\beta_r x_r} - \\lambda = 0 $$\n$$ \\frac{\\partial \\mathcal{L}}{\\partial \\lambda} = -(x_s + x_\\ell + x_r - B) = 0 \\implies x_s + x_\\ell + x_r = B $$\nFrom the first three equations, we can express each $x_i$ in terms of the Lagrange multiplier $\\lambda$. We assume an interior solution where $x_s, x_\\ell, x_r  0$.\n\nFrom $\\frac{w_s \\beta_s}{1+\\beta_s x_s} = \\lambda$, we get $1+\\beta_s x_s = \\frac{w_s \\beta_s}{\\lambda}$, which implies $\\beta_s x_s = \\frac{w_s \\beta_s}{\\lambda} - 1$.\n$$ x_s = \\frac{1}{\\beta_s} \\left( \\frac{w_s \\beta_s}{\\lambda} - 1 \\right) = \\frac{w_s}{\\lambda} - \\frac{1}{\\beta_s} $$\nSimilarly, for $x_\\ell$ and $x_r$:\n$$ x_\\ell = \\frac{w_\\ell}{\\lambda} - \\frac{1}{\\beta_\\ell} $$\n$$ x_r = \\frac{w_r}{\\lambda} - \\frac{1}{\\beta_r} $$\nFor these solutions to be valid (i.e., $x_i  0$), we must have $\\lambda  w_i \\beta_i$ for each $i \\in \\{s, \\ell, r\\}$.\n\nNow, we substitute these expressions for $x_s$, $x_\\ell$, and $x_r$ into the budget constraint:\n$$ \\left(\\frac{w_s}{\\lambda} - \\frac{1}{\\beta_s}\\right) + \\left(\\frac{w_\\ell}{\\lambda} - \\frac{1}{\\beta_\\ell}\\right) + \\left(\\frac{w_r}{\\lambda} - \\frac{1}{\\beta_r}\\right) = B $$\nFactoring out $\\frac{1}{\\lambda}$ gives:\n$$ \\frac{1}{\\lambda}(w_s + w_\\ell + w_r) - \\left(\\frac{1}{\\beta_s} + \\frac{1}{\\beta_\\ell} + \\frac{1}{\\beta_r}\\right) = B $$\nLet $W = w_s + w_\\ell + w_r$ and $S_\\beta = \\frac{1}{\\beta_s} + \\frac{1}{\\beta_\\ell} + \\frac{1}{\\beta_r}$. The equation becomes:\n$$ \\frac{W}{\\lambda} - S_\\beta = B \\implies \\frac{W}{\\lambda} = B + S_\\beta \\implies \\lambda = \\frac{W}{B + S_\\beta} $$\nNow, we substitute the given numerical values:\n$B=10$\n$w_s=0.5, w_\\ell=0.3, w_r=0.2 \\implies W = 0.5+0.3+0.2 = 1.0$\n$\\beta_s=0.25 \\implies 1/\\beta_s = 1/0.25 = 4$\n$\\beta_\\ell=0.20 \\implies 1/\\beta_\\ell = 1/0.20 = 5$\n$\\beta_r=0.50 \\implies 1/\\beta_r = 1/0.50 = 2$\n$S_\\beta = 4 + 5 + 2 = 11$\n\nWe can now compute the value of $\\lambda$:\n$$ \\lambda = \\frac{1.0}{10 + 11} = \\frac{1}{21} $$\nLet's check the condition for an interior solution ($x_i  0$). This requires $\\lambda  w_i \\beta_i$ for all $i$.\n$w_s \\beta_s = 0.5 \\times 0.25 = 0.125$\n$w_\\ell \\beta_\\ell = 0.3 \\times 0.20 = 0.06$\n$w_r \\beta_r = 0.2 \\times 0.50 = 0.10$\nThe value of our Lagrange multiplier is $\\lambda = 1/21 \\approx 0.047619$.\nSince $0.047619  0.125$, $0.047619  0.06$, and $0.047619  0.10$, the conditions are satisfied, confirming that the optimal allocation is an interior solution with $x_s  0, x_\\ell  0, x_r  0$.\n\nFinally, we calculate the optimal allocations $x_s^{\\star}, x_\\ell^{\\star}, x_r^{\\star}$:\n$$ x_s^{\\star} = \\frac{w_s}{\\lambda} - \\frac{1}{\\beta_s} = \\frac{0.5}{1/21} - 4 = 0.5 \\times 21 - 4 = 10.5 - 4 = 6.5 $$\n$$ x_\\ell^{\\star} = \\frac{w_\\ell}{\\lambda} - \\frac{1}{\\beta_\\ell} = \\frac{0.3}{1/21} - 5 = 0.3 \\times 21 - 5 = 6.3 - 5 = 1.3 $$\n$$ x_r^{\\star} = \\frac{w_r}{\\lambda} - \\frac{1}{\\beta_r} = \\frac{0.2}{1/21} - 2 = 0.2 \\times 21 - 2 = 4.2 - 2 = 2.2 $$\nThe optimal allocations are $(x_s^{\\star}, x_\\ell^{\\star}, x_r^{\\star}) = (6.5, 1.3, 2.2)$ million USD.\n\nTo verify, we check the budget constraint:\n$x_s^{\\star} + x_\\ell^{\\star} + x_r^{\\star} = 6.5 + 1.3 + 2.2 = 10.0$\nThis matches the total budget $B=10$.\n\nThe problem states to round each allocation to four significant figures.\n$x_s^{\\star} = 6.500$\n$x_\\ell^{\\star} = 1.300$\n$x_r^{\\star} = 2.200$\n\nThe final optimal allocation is $\\big(x_{s}^{\\star},x_{\\ell}^{\\star},x_{r}^{\\star}\\big) = (6.500, 1.300, 2.200)$ million USD.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n6.500  1.300  2.200\n\\end{pmatrix}\n}\n$$", "id": "4528882"}]}